Studies in BON1 cells transiently overexpressing Notch1 NICD resulted in growth suppression, dose-dependent increases in Hes1, and a decrease in NET markers, confirming the tumor-suppressor function of Notch1 signaling in pancreatic NETs. The gene discussed is NOTCH1; the disease is neoplasm.